Market sharing infringement was correctly proven, says CMA counsel

The UK’s antitrust authority has pushed back against members of the Prochlorperazine cartel that claim it failed to meet the burden of proof when levying fines in 2022, telling the Competition Appeal Tribunal that their defence relies on several improbable coincidences and mistakes.

Unlock unlimited access to all Global Competition Review content